Breaking News, Financial News

Financial Report: BASi

Results reflect higher revenues in both the service and product segments, as well as $265,000 of reduced operating expenses.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi 1Q Revenues: $8.1 million (+27%) 1Q Earnings: $310,000(loss of $1.5 million 1Q10) Comments: Results reflect higher revenues in both the service and product segments, as well as $265,000 of reduced operating expenses. Service revenue was up 28% to $6.1 million in the quarter and product revenue was up 24% to $1.9 million. Click here to learn more about BASi....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters